Orgaran 750 Unit (Danaparoid Sodium SOLUTION) 750 UNIT

Orgaran 750 Unit is a solution containing danaparoid sodium, used for anticoagulation therapy. This intravenous medication helps prevent blood clots, offering a reliable option for managing certain medical conditions.

Strength

750 UNIT

Pack Size

10X0.6ML AMPS

Manufacturer / TM Owner

ASPEN PHARMACARE CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Orgaran 750 Unit, containing danaparoid sodium, is primarily used for anticoagulation. It is often prescribed to prevent blood clots in situations where other anticoagulants may not be suitable. This medication is commonly used in hospital settings for patients requiring intravenous administration to manage or prevent clotting disorders.

Side Effects

Orgaran 750 Unit may cause common effects such as bleeding, bruising, or injection site reactions. Some users might experience allergic reactions, though these are less frequent. Always consult a healthcare provider for personalized advice on managing any side effects.

Precautions & Warnings

Orgaran 750 Unit should be handled with care, especially by those with a history of bleeding disorders or allergies to similar medications. It is crucial to follow the prescribed dosage and administration guidelines to minimize risks. Store the solution as directed to maintain its effectiveness.

Avoid Interactions

Orgaran 750 Unit may interact with other anticoagulants, antiplatelet drugs, or medications that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Orgaran 750 Unit is used for anticoagulation to prevent blood clots in situations where other anticoagulants may not be suitable.

Orgaran 750 Unit is administered intravenously, typically in a hospital setting.

Common side effects may include bleeding, bruising, or injection site reactions.

Orgaran 750 Unit may interact with other anticoagulants or antiplatelet drugs, so it's important to consult a healthcare provider.

Orgaran 750 Unit should be stored according to the manufacturer's instructions to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.